Supernus Pharmaceuticals, Inc. (SUPN) Earnings
NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic
$44.56
-2.17%
Mkt Cap $2.64B
EPS — Estimate vs Actual
Mkt Cap
$2.64B
P/E
—
Fwd P/E
25.99
P/S
3.40
Rev TTM
—
EPS TTM
-$0.51
NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic
$44.56
-2.17%
Mkt Cap $2.64B
Mkt Cap
$2.64B
P/E
—
Fwd P/E
25.99
P/S
3.40
Rev TTM
—
EPS TTM
-$0.51